Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Matinas BioPharma Holdings, Inc. received a notice from the NYSE American stating the company is not in compliance with continued listing standards due to stockholders' equity falling below required levels amidst ongoing losses. The company has an accepted plan to regain compliance by October 2027, during which its stock remains listed but marked a…